中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
金属研究所 [3]
合肥物质科学研究院 [1]
采集方式
OAI收割 [4]
内容类型
期刊论文 [4]
发表日期
2020 [1]
2015 [2]
2014 [1]
学科主题
筛选
浏览/检索结果:
共4条,第1-4条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
He, Chiyu
;
Qian, Yu
;
Liu, Bin
;
Yang, Shaoxue
;
Ye, Ding
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2020/12/28
C-reactive protein
genome-wide association study
Mendelian randomization
prostate cancer
single-nucleotide polymorphisms
Synthesis and antiproliferative activity of novel 4-substituted-phenoxy-benzamide derivatives
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2015, 卷号: 26, 期号: 10, 页码: 1307-1310
作者:
Sun ChiYu
;
Li YangSheng
;
Shi AiLong
;
Li YaFei
;
Cao RuiFang
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2021/02/02
HEDGEHOG SIGNALING PATHWAY
BASAL-CELL CARCINOMA
INHIBITORS
DISCOVERY
DESIGN
ANTAGONISTS
IDENTIFICATION
VISMODEGIB
CANCER
POTENT
Aryl cycloaliphatic amine
Antiproliferative activity
Hedgehog signaling
Synthesis and antiproliferative activity of novel 4-substituted-phenoxy-benzamide derivatives
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2015, 卷号: 26, 期号: 10, 页码: 1307-1310
作者:
Sun ChiYu
;
Li YangSheng
;
Shi AiLong
;
Li YaFei
;
Cao RuiFang
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2021/02/02
HEDGEHOG SIGNALING PATHWAY
BASAL-CELL CARCINOMA
INHIBITORS
DISCOVERY
DESIGN
ANTAGONISTS
IDENTIFICATION
VISMODEGIB
CANCER
POTENT
Aryl cycloaliphatic amine
Antiproliferative activity
Hedgehog signaling
Design, Synthesis and Antitumor Activity of Pyrrolopyrazinone-chalcone Hybrids
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2014, 卷号: 30, 期号: 4, 页码: 624-631
作者:
Meng Ying
;
Zhang Hongwei
;
Liu Zehua
;
Zeng Shanchao
;
Zhang Hongwei
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2021/02/02
DERIVATIVES
CELL
HYDROXYCHALCONES
AGENTS
Pyrrolopyrazinone-chalcone hybrid
Antitumor
Marine sponge
Combination principle